ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

473

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

August 22, 2022

Study Completion Date

November 20, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

Remdesivir

Administered by IV infusion, daily for 10 days. Initial loading dose is 200 mg with all subsequent doses 100 mg.

DRUG

Remdesivir Placebo

Commercially available 0.9% sodium chloride solution. Administered by IV infusion daily for 10 days.

BIOLOGICAL

Aviptadil

Administered by IV infusion over 12 hours per day for 3 days. Participants are no longer being randomized to this intervention.

DRUG

Aviptadil Placebo

Commercially available 0.9% sodium chloride solution. Administered by IV infusion over 12 hours per day for 3 days.

DRUG

Corticosteroid

In line with NIH treatment guidelines, corticosteroids such as dexamethasone, prednisone, methylprednisolone or hydrocortisone may be administered as SOC.

Trial Locations (40)

10029

Mount Sinai Medical Center (Site 301-012), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York

10032

Columbia University Irving Medical Center (Site 301-027), 177 Fort Washington Ave., New York

10467

Montefiore Medical Center - Moses Hospital (Site 206-001), 111 E. 210th Street, The Bronx

Montefiore Medical Center - Weiler campus (Site 206-003), 111 E. 210th Street, The Bronx

20010

MedStar Health Research Institute (Site 009-021), 110 Irving St., NW., Washington D.C.

20422

Washington DC VA Medical Center (Site 009-004), 50 Irving Street, NW., Washington D.C.

22908

UVA School of Medicine (Site 210-003), University of Virginia Health System, University Hospital, 1215 Lee St., Charlottesville

26506

West Virginia University Medicine (Site 301-023), One Medical Center Drive, Morgantown

27157

Wake Forest Baptist Health (Site 210-001), Medical Center Blvd, Winston-Salem

27710

Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham

29425

Medical University of South Carolina (Site 210-002), 96 Jonathan Lucas St., CSB 214, Charleston

30322

Emory University (Site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., NE., Atlanta

37232

Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive, Nashville

43210

The Ohio State University Wexner Medical Center (Site 207-004), 410 W. 10th Avenue, Columbus

44111

Cleveland Clinic Fairview Hosptial (Site 207-005), 18101 Lorain Ave., Cleveland

44124

Cleveland Clinic Hillcrest Hospital (Site 207-007), 6780 Mayfield Road, Mayfield Heights

44125

Cleveland Clinic Marymount Campus (Site 207-006), 12300 McCracken Road, Garfield Heights

44195

Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Ave., Cleveland

45219

University of Cincinnati Medical Center (Site 207-003), 234 Goodman Street, ML 0740, Cincinnati

75246

Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave., Dallas

77030

Houston Methodist Hospital (Site 301-028), 6565 Fannin Street, Houston

Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266, Houston

University of Texas Health Science Center (Site 203-006), 7000 Fannin St., Houston

80045

University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue, Aurora

80204

Denver Health Medical Center (Site 204-004), 780 Delaware Street, Pavilion B, Denver

84107

Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street, Murray

84132

University of Utah Hospital (Site 211-002), 50 North Medical Drive, Salt Lake City

85719

Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue, Tucson

90048

Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Boulevard, Los Angeles

90095

Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza, Los Angeles

92357

VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street, Loma Linda

93701

UCSF Fresno (Site 203-005), 155 N. Fresno Street, Fresno

94115

UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St., San Francisco

94143

UCSF Medical Center (Site 203-001), Moffit-Long Hospital, 505 Parnassus Ave., San Francisco

94305

Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr., Stanford

98104

Harborview Medical Center (Site 208-001), 325 9th Ave., Seattle

98122

Swedish Medical Center (Site 208-005), 747 Broadway, Seattle

02114

Massachusetts General Hospital (Site 202-002), 55 Fruit Street, Boston

01199

Baystate Medical Center (Site 201-001), Critical Care Research, 759 Chestnut Street, Springfield

97239-3098

Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd., Portland

All Listed Sponsors
collaborator

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

NETWORK

collaborator

University of Copenhagen

OTHER

collaborator

Medical Research Council

OTHER_GOV

collaborator

Kirby Institute

OTHER_GOV

collaborator

Washington D.C. Veterans Affairs Medical Center

FED

collaborator

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

US Department of Veterans Affairs

FED

collaborator

Prevention and Early Treatment of Acute Lung Injury

OTHER

collaborator

Cardiothoracic Surgical Trials Network

OTHER

collaborator

NeuroRx, Inc.

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH